Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Hiromoto Tei
Mp37-13 Accelerated Cell Proliferation and Enhanced Resistance to Docetaxel by Inhibition of 4e-Binding Protein 1 Expression in Human Castration-Resistant Prostate Cancer Pc3 Cells
Journal of Urology
Urology
Related publications
Salvage Therapy for Castration-Refractory Prostate Cancer Resistant to Docetaxel
Japanese Journal of Urology
Urology
ERG Rearrangement and Protein Expression in the Progression to Castration-Resistant Prostate Cancer
Prostate Cancer and Prostatic Diseases
Cancer Research
Oncology
Urology
Docetaxel Rechallenge in Patients With Castration-Resistant Prostate Cancer — A Review
European Oncology and Haematology
Oncology
Hematology
MMP-7, sFas and FasL Serum Levels for Predicting Docetaxel Resistance and Survival in Castration-Resistant Prostate Cancer
BJU International
Urology
Targeting Cancer Stem Cells in Castration-Resistant Prostate Cancer
Clinical Cancer Research
Cancer Research
Oncology
Resistance to Novel Antiandrogen Therapies in Metastatic Castration-Resistant Prostate Cancer
Clinical Medicine Insights: Oncology
Oncology
Targeted BikDD Expression Kills Androgen-Dependent and Castration-Resistant Prostate Cancer Cells
Molecular Cancer Therapeutics
Cancer Research
Oncology
PKM2 Under Hypoxic Environment Causes Resistance to mTOR Inhibitor in Human Castration Resistant Prostate Cancer
Oncotarget
Oncology
Inhibitor SBFI26 Suppresses the Malignant Progression of Castration-Resistant PC3-M Cells by Competitively Binding to Oncogenic FABP5
Oncotarget
Oncology
